For the quarter ending 2025-09-30, USPH had -$2,984K decrease in cash & cash equivalents over the period. $15,625K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income including non-controlling interest | 17,642 | 31,188 |
| Depreciation and amortization | 5,832 | 11,924 |
| Provision for credit losses | 2,073 | 3,843 |
| Equity-based awards compensation expense | 2,263 | 3,888 |
| Amortization of debt issue costs | 105 | 210 |
| Change in deferred income taxes | 3,884 | 7,279 |
| Change in revaluation of put-right liability | -663 | -743 |
| Change in fair value of contingent earn-out consideration | 5,872 | 5,612 |
| Equity of earnings in unconsolidated affiliate | 361 | 794 |
| Loss on sale of fixed assets | 18 | -438 |
| Loss on sale of a partnership | 0 | -123 |
| Other | 0 | - |
| Patient accounts receivable, net | 3,372 | 10,232 |
| Accounts receivable - other | -3,204 | -355 |
| Other current and long term assets | 3,729 | 4,426 |
| Accounts payable and accrued expenses | -2,994 | -7,914 |
| Other long-term liabilities | 620 | -827 |
| Net cash provided by operating activities | 19,940 | 30,186 |
| Purchase of fixed assets | 4,315 | 5,830 |
| Purchase of interest in businesses, net of cash acquired | 8,324 | 6,890 |
| Purchase of redeemable non-controlling interest, temporary equity | 152 | 8,427 |
| Repayment of notes receivable related to redeemable non-controlling interest | - | 346 |
| Purchase of non controlling interest, permanent equity | 47 | 149 |
| Proceeds from the sale of non-controlling interest, permanent equity | 0 | 9 |
| Proceeds from the sale of partnership interest - redeemable non-controlling interest, temporary equity | 134 | 15 |
| Repayment of notes receivable related to sales of redeemable non-controlling interest | 387 | - |
| Proceeds from the sale of partnership | 0 | 700 |
| Distributions from unconsolidated affiliate | 425 | 664 |
| Other | -303 | -228 |
| Net cash (used in) investing activities | -11,935 | -19,334 |
| Proceeds from revolving facility | 73,000 | 73,500 |
| Payments on revolving facility | 71,000 | 60,000 |
| Distributions to non-controlling interest, permanent and temporary equity | 3,913 | 10,697 |
| Cash dividends paid to shareholders | 6,842 | 13,678 |
| Payments on term loan | 1,875 | 5,625 |
| Principal payments on notes payable | 366 | 1,628 |
| Other | 7 | - |
| Net cash (used in) financing activities | -10,989 | -18,128 |
| Net (decrease) in cash and cash equivalents | -2,984 | -7,276 |
| Cash and cash equivalents at beginning of period | 41,362 | - |
| Cash and cash equivalents at end of period | 31,102 | - |
U S PHYSICAL THERAPY INC NV (USPH)
U S PHYSICAL THERAPY INC NV (USPH)